Evotec SE (EVO) Cash & Equivalents (2009 - 2026)

Evotec SE has disclosed Cash & Equivalents across 10 years of filings, most recently posting $404.9 million for Q2 2026.

• In Q2 2026, Cash & Equivalents rose 33.56% year-over-year to $404.9 million; the TTM figure through Jun 2026 stood at $404.9 million (up 33.56% YoY), while the FY2025 annual figure was $472.8 million, up 42.59% from the prior year.
• Cash & Equivalents came in at $404.9 million for Q2 2026 at Evotec SE, down from $454.1 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $743.7 million in Q2 2022 to a low of $203.5 million in Q3 2025.
• Average Cash & Equivalents over 5 years is $441.8 million, with a median of $454.1 million recorded in 2026.
• Year-over-year, Cash & Equivalents slumped 47.06% in 2022 and surged 51.29% in 2026.
• Over 5 years, Cash & Equivalents stood at $423.6 million in 2022, then advanced by 29.78% to $549.7 million in 2023, then plunged by 40.44% to $327.4 million in 2024, then surged by 48.8% to $487.2 million in 2025, then slipped by 16.88% to $404.9 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $404.9 million in Q2 2026, $454.1 million in Q1 2026, and $487.2 million in Q4 2025.